Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-08-10

FDA Approved: LEVETIRACETAM — Supplemental Application (Cranbury Pharmaceuticals, LLC)

View source ↗

Summary

FDA approved a supplemental application for levetiracetam (generic) submitted by Cranbury Pharmaceuticals, LLC. The action reflects an updated approval status f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVETIRACETAM (levetiracetam)

Snippet

SUPPL AP for LEVETIRACETAM (LEVETIRACETAM)